Australia New Zealand Food Standards Code – Standard 3.4.1 – Food safety requirements for processing of cell-cultured food

The Standard defines a compact set of core concepts that determine scope and obligations. These definitions are normative, they drive which businesses and activities are in scope, and they set technical thresholds for compliance.

• Cell line (3.4.1,2): A cell line must be derived from a single source prepared under specific culture conditions, must have a uniform composition, and must be intended for use in producing a cell biomass. The definition links compositional uniformity and single‑source origin to regulatory treatment, so mixed or composite culture origins fall outside the textual definition of a cell line used by the Standard.
• Assessed cell line (3.4.1,2): This term means a cell line listed in section S25A,6. The Standard mandates use of an assessed cell line for proliferation (3.4.1,7), creating an externalised gating mechanism: the permissibility of cell lines for proliferation depends on inclusion in a separate list, not on criteria stated within this instrument.
• Cell biomass (3.4.1,2): Cell biomass is defined as a mass of cells extracted from a bioreactor and intended for food production. The Standard then treats cell biomass as a potentially hazardous food under Standard 3.2.2 (3.4.1,8), linking handling and storage to the Code’s hazardous food regime.
• Cell culturing food business and cell line supplier (3.4.1,2): The instrument distinguishes between the business that undertakes cell proliferation (cell culturing food business), and the business that sources cells and creates cell lines (cell line supplier). The cell line supplier definition explicitly includes both sourcing and creation activities, thereby attaching the cell line supplier duties to entities that do both.
• Cell proliferation, differentiation, and extraction (3.4.1,2): These process definitions map the production lifecycle. Cell proliferation is production of cell biomass; cell differentiation is induction into final cell types; and cell extraction covers extraction from bioreactor or separation via sedimentation, centrifugation or other action. By defining these activities, the Standard anchors the obligations in the lifecycle steps listed in the food safety program requirements (3.4.1,5(2)(b)).
• Bioreactor and media (3.4.1,2): A bioreactor is defined as a device where cell proliferation occurs under closed and controlled conditions. Media is a growth medium used for proliferation and/or differentiation. The references set up expectations about closed, controlled environments and the role of growth media as an input that may affect safety.

Other cross‑references shape concepts by reference rather than definition. For example, the Standard declares that cell biomass is a potentially hazardous food for the purposes of Standard 3.2.2 (3.4.1,8), importing the Code’s hazardous‑food concept. It also requires compliance with Standard 3.2.1 for food safety programs (3.4.1,5(1)), thereby bundling the cell culturing business requirements with the broader food safety program obligations in the Code.

The Standard also creates a traceability concept in two contexts: for cell line suppliers, traceability must follow cells from donor animal collection through supply, identify the donor animal, and record recipients (3.4.1,4). For cell culturing businesses, traceability must identify the cell line used, the supplier, and recipients of cell biomass (3.4.1,9). The traceability obligations therefore establish parallel chain‑of‑custody duties at both supply and processing nodes.

Finally, the Standard’s reliance on an external list of assessed cell lines (S25A,6) and on other Code Standards (3.2.1, 3.2.2) means the substantive permissibility and risk classification of particular lines or products depends on instruments not reproduced here.

The text draws a clear actor map and shifts obligations to particular commercial roles in the cell‑cultured food production chain.

Primary regulated actors

• Cell line suppliers (3.4.1,2, 3.4.1,3, 3.4.1,4). The definition requires an entity to perform both sourcing of cells for creating a cell line and creation of a cell line to fall within the cell line supplier role. These entities must ensure lines are free of bacteria, fungi, prions and viruses (3.4.1,3(1)), identify and record species (3.4.1,3(2)), ensure donor animals are free of disease (3.4.1,3(3)), and maintain a traceability system that records collection, donor animal identity and supply recipients (3.4.1,4).
• Cell culturing food businesses (3.4.1,2, 3.4.1,5 to 3.4.1,9). These are businesses, enterprises or activities that undertake cell proliferation. They must hold and operate a food safety program in compliance with Standard 3.2.1 (3.4.1,5(1)), include specified process‑control elements (3.4.1,5(2)), ensure inputs do not make the food unsafe (3.4.1,6), use only assessed cell lines for proliferation (3.4.1,7), treat cell biomass as potentially hazardous pursuant to Standard 3.2.2 (3.4.1,8), and maintain traceability of cell lines, suppliers and recipients (3.4.1,9).

Secondary affected parties

• Suppliers of media and other inputs. The Standard obliges cell culturing businesses to ensure any substance used in proliferation, differentiation, extraction, handling or storage does not make cell‑cultured food unsafe or unsuitable (3.4.1,6). That requirement places compliance pressure on buyers and users of media, reagents and storage materials to obtain evidence of safety from suppliers.
• Donor animals and farms. The Standard requires donor animals to be free of disease for purposes of sourcing cell lines (3.4.1,3(3)). While donor animals are not legal entities, their health status becomes a formal compliance criterion for cell line suppliers, implying testing and documentation costs for those suppliers.
• Recipients and downstream processors. Both cell line suppliers and cell culturing businesses must identify to whom they supplied cell lines or cell biomass (3.4.1,4(c); 3.4.1,9(c)). Recipients , which could include further processors, packers, distributors or retailers , become nodes in traceability chains and may bear record‑keeping duties that arise out of commercial contractual expectations flowing from the Standard.
• Regulators and enforcement agents. The Standard is issued under the FSANZ Act and is part of the Food Standards Code (note 1). The instrument itself does not list enforcement agencies or penalties, but by creating Code obligations it sets compliance expectations that relevant food regulators will act upon under their respective enforcement frameworks.

Who pays and who decides

• Costs will fall primarily on cell line suppliers and cell culturing food businesses who must implement testing, documentation, traceability systems, calibrated and sterilised equipment, and food safety program elements (3.4.1,3, 3.4.1,4, 3.4.1,5(2)(d)). Decisions about which cell lines may be proliferated are constrained by the assessed cell line list S25A,6, referenced in the Standard (3.4.1,2; 3.4.1,7).
• Decisions about when proliferation is non‑conforming, when to clean or sterilise equipment and how to calibrate relevant devices sit with the cell culturing food business via the food safety program requirements (3.4.1,5(2)(c) and (d)). The Standard prescribes the subjects that must be addressed but leaves the specific technical choices to the business to document and implement.

Scope limitations

• The instrument states it applies in Australia only (note 2). It is not expressed to apply in New Zealand, despite being a Standard of the Australia New Zealand Food Standards Code.
• The Standard’s gates rely on an external list of assessed cell lines (S25A,6). Entities seeking to proliferate cell lines must confirm whether a line is included in that external list.

The Standard creates specific, enumerated duties for two distinct actor types and sets out what those duties must cover. The instrument does not grant positive rights such as approvals in the text; it specifies performance obligations and cross‑references other Code requirements.

Duties imposed on cell line suppliers

• Absence of specific biological hazards. A cell line supplier must ensure a cell line does not contain bacteria, fungi, prions or viruses (3.4.1,3(1)). This duty is a negative obligation to prevent contamination or presence of listed biological agents within the cell line.
• Identification and recording. A cell line supplier must identify and record the species of the cells comprising a cell line (3.4.1,3(2)). The duty requires maintainable, recorded species identification information.
• Donor animal health. Cell lines must be sourced from donor animals free of disease (3.4.1,3(3)). The supplier must ensure or verify donor animal health prior to sourcing.
• Traceability system. The supplier must have a system that:
  • identifies and tracks cells from collection to supply of a cell line;
  • identifies the donor animal for cells used to develop each cell line; and
  • identifies to whom a cell line was supplied (3.4.1,4). This is a three‑part traceability duty, covering origin, donor identity and downstream recipient identification.

Duties imposed on cell culturing food businesses

• Food safety program compliance. A cell culturing food business must comply with Standard 3.2.1 (3.4.1,5(1)). The Standard 3.2.1 reference brings the existing Code’s food safety program architecture into scope for these businesses.
• Content of the food safety program. In addition to the general requirements of Standard 3.2.1, the cell culturing food business’s food safety program must detail:
  • indicators of a loss of process control in a bioreactor (3.4.1,5(2)(a));
  • food handling activities related to cell sourcing, selection and banking; cell proliferation including serial sub‑culturing in flasks; seeding and proliferation in bioreactors; cell differentiation; and cell extraction (3.4.1,5(2)(b)(i)-(v));
  • how the business will identify when cell proliferation is non‑conforming (3.4.1,5(2)(c)); and
  • how the business will undertake calibration, cleaning and sterilisation of all relevant equipment (3.4.1,5(2)(d)).
• Inputs safety. Any substance used in or for cell proliferation, differentiation, extraction, handling or storage must not make the cell‑cultured food unsafe or unsuitable (3.4.1,6). This is a broad negative duty on inputs used across the lifecycle.
• Use of assessed cell lines. A cell culturing food business must only use an assessed cell line for cell proliferation (3.4.1,7). This is a gating duty tied to an external list (S25A,6).
• Hazard classification. A cell biomass is expressly captured as a potentially hazardous food under Standard 3.2.2 (3.4.1,8). This imports the Code’s handling and control expectations for potentially hazardous foods.
• Traceability. A cell culturing food business must have a system that identifies the cell line used for proliferation, the supplier of that cell line, and to whom the cell biomass was supplied (3.4.1,9).

Rights and omissions in the text

• The Standard does not confer explicit operational approvals or licences within its text. Its operative content consists of duties and cross‑references.
• The Standard does not set out inspection or enforcement procedures, nor does it list penalties or specify regulatory agencies within the instrument. Those matters are outside the text provided.
• The Standard references an external list of assessed cell lines (S25A,6), which functions as a control point. Inclusion on that list appears to be a necessary precondition for use in proliferation, but the Standard does not describe the criteria or process for listing in S25A,6 within its text.

Practical consequence of the duties

• The duties create record‑keeping and procedural obligations: species records, donor health records, chain‑of‑custody records for supply, calibration and sterilisation protocols, and documented indicators for process control and non‑conformance. The Standard prescribes subjects that must be documented; it leaves the technical implementations to businesses in their food safety programs.

The Standard, in the text provided, does not specify penalties, fines or enforcement mechanisms. It is a Standard under the Food Standards Australia New Zealand Act 1991 (Cth) and forms part of the Australia New Zealand Food Standards Code (note 1), but the instrument itself contains no provisions describing enforcement authorities, inspection powers, administrative sanctions or criminal penalties. The instrument also does not expressly describe timelines for compliance, record retention periods, or audit regimes.

What the instrument does state with enforcement relevance

• It is made under section 92 of the FSANZ Act and commences on the date of gazettal (3.4.1,1 and the introductory notice), which establishes the Standard as part of the Code from that date. The fact of gazettal is recorded (Gazette No. FSC 179 dated 18 June 2025 in the instrument’s note). The Standard’s legal status as part of the Code means it will be enforceable through the general legal and regulatory framework that applies to the Code, but the instrument itself does not set out which agencies will enforce it or how.
• The Standard imports other Code instruments with enforcement implications, notably Standard 3.2.1 (food safety program obligations) and Standard 3.2.2 (potentially hazardous foods). Any enforcement regime attached to those Standards will be relevant to the obligations created here, but the precise enforcement measures applicable to a contravention of Standard 3.4.1 are not specified in the text.

Implications of silence on penalties

• Businesses cannot rely on the Standard’s text to determine statutory penalties or enforcement processes. Practitioners will need to consult the broader statutory framework, the FSANZ Act, and the enforcement arrangements of the relevant state or territory food regulator to identify specific sanctions and inspection regimes that apply to contraventions of the Code.
• The absence of penalty language in the Standard means the instrument is framed as substantive regulatory obligations, but operational enforcement will depend on the application of general enforcement mechanisms for the Food Standards Code within Australia’s federal and state regulatory architecture, which the instrument does not describe.

For compliance planning, businesses must therefore treat the duties as binding obligations from the date of gazettal, prepare to demonstrate compliance as per the Standard’s documentary and program requirements, and expect scrutiny under whatever enforcement tools relevant regulators have for breaches of the Code, even though those enforcement provisions are not contained in this instrument.

This Standard is framed within the architecture of the Australia New Zealand Food Standards Code and cross‑references specific Code standards and legislative provisions. The Standard’s interactions are textual and structural rather than procedural within the instrument.

Direct textual cross‑references inside the Code

• Standard 3.2.1. The Standard requires a cell culturing food business to comply with Standard 3.2.1 (3.4.1,5(1)). Standard 3.2.1 is the Code provision governing food safety programs; by reference the new Standard grafts its cell‑culture specific program content onto the existing food safety program framework. The instrument therefore modifies required program content by cross‑reference, while leaving the broader administrative contours of Standard 3.2.1 to operate.
• Standard 3.2.2. The Standard declares a cell biomass to be a potentially hazardous food for the purposes of Standard 3.2.2 (3.4.1,8). This classification imports the handling, storage and control expectations associated with potentially hazardous foods into the cell biomass context.
• Section 1.1.1,3. The instrument references the Code’s structure and the role of Standards within it (note 1 under the Standard cites section 1.1.1,3). That cross‑reference locates the Standard structurally as part of the Code.

External list of assessed cell lines

• The Standard’s requirement that only an assessed cell line be used for proliferation (3.4.1,7) ties permissibility to the list in section S25A,6, which is outside the body of this instrument. The legal effect is that proliferation is permitted only if the line appears on that external list. The Standard does not set criteria, processes, or timelines for listing in S25A,6, so the operational interaction depends on that separate list and any statutory or administrative rules applicable to its maintenance.

Legislative provenance and commencement

• The Standard is made under the Food Standards Australia New Zealand Act 1991 (Cth) and commences on gazettal under section 92 of that Act, with reference to section 93 for the commencement mechanism (3.4.1,1 and the introductory material). This links the Standard to the FSANZ Act’s rulemaking and gazettal procedures and situates it as binding from the date of gazettal described in the notice.

Geographical scope

• The instrument expressly applies in Australia only (note 2), even though it is a Standard of an instrument that also operates in New Zealand for other standards. Therefore, any interaction with New Zealand food law is excluded by the instrument’s text.

On enforcement and penalties

• The instrument does not specify enforcement provisions or penalties. Interaction with enforcement regimes therefore depends on the enforcement powers and procedures of the agencies that apply the Code in Australia, which are not stated in the Standard. The Standard’s requirements will intersect with state and territory food regulation enforcement mechanisms, but those mechanisms are external to the text.

Consequences of the cross‑references

• The cross‑references make practical compliance dependent on at least three documents: this Standard (3.4.1), Standard 3.2.1 and Standard 3.2.2, and the assessed cell line list S25A,6. For a business to demonstrate compliance it must therefore consider the content of all referenced Code provisions and the external list. The Standard structures obligations by reference rather than by restatement, thereby centralising technical detail in separate instruments.

The instrument itself contains limited amendment metadata. The Standard is presented as a new Code Standard, dated 10 June 2025, with a Board delegate signature and a notice that the Standard will be published in the Commonwealth of Australia Gazette No. FSC 179 on 18 June 2025. The instrument states explicitly that the Standard commences on the date of gazettal, being the date specified as the commencement date in notices in the Gazette under section 92 of the Food Standards Australia New Zealand Act 1991 (Cth) (3.4.1,1 and accompanying note).

Recorded steps and dates in the instrument

• Board decision and signature: The notice is dated 10 June 2025 and signed by Matthew O’Mullane, General Manager, Food Safety, as delegate of the Board of Food Standards Australia New Zealand.
• Gazettal date: The instrument states it will be published in Gazette No. FSC 179 on 18 June 2025 and identifies that date as the gazettal date for the purposes of commencement.
• Commencement mechanism: The Standard commences on the date of gazettal under s 92 of the FSANZ Act, with a cross‑reference to s 93 in the note to section 3.4.1,1.

What the instrument does not record

• There is no record within the text of prior versions, repeal of earlier Standards, transitional arrangements, or staged implementation periods. The Standard contains no formal amendment schedule or savings provisions.
• The instrument does not reproduce or describe the assessed cell line list S25A,6, nor does it state when or how that list might be updated or amended.
• There are no recorded amendments, repeal clauses or sunset clauses in the text provided.

Practical consequence for practitioners

• For tracing amendment history beyond the creation and gazettal recorded here, practitioners must consult the Gazette entry cited (FSC 179 dated 18 June 2025) and FSANZ administrative records. Any subsequent amendments to S25A,6 or to Standards 3.2.1 and 3.2.2 that affect the operation of this Standard will be recorded in later Gazettes or in subsequent Code amendments; they are not addressed in this instrument.

The Standard as provided contains no litigation history. The instrument does not reference any judicial decisions, reviews, appeals, or disputes relating to its content or to the board’s making of the Standard. It does not report any court challenges to the standard, nor does it cite tribunal determinations.

What the absence of litigation history in the text means for legal research

• The lack of litigation references in the Standard itself is not the same as the absence of judicial engagement with the subject matter in other forums. However, within the four corners of this instrument there are no named cases or legal proceedings.
• Practitioners seeking litigation precedent relevant to interpretation of the duties or to enforcement actions under this Standard will need to search external sources: court databases, administrative review records, and enforcement agency decisions. The Standard’s text gives no guidance on precedent or prior adjudications.

Practical implications for litigation risk and counsel

• Because the Standard introduces novel duties relating to cell lines and cell biomass, potential future disputes could arise around interpretation of key terms (for example, what constitutes an assessed cell line under S25A,6, or how a traceability system meets the Standard’s requirements). The instrument itself does not supply interpretations or illustrative examples.
• Any litigation that emerges will likely engage issues external to the Standard text, including the evidential adequacy of species identification, the adequacy of donor animal health verification, the sufficiency of traceability systems, and the adequacy of food safety programs that address the enumerated items in 3.4.1,5(2). None of those dispute outcomes are recorded in the Standard.

For now, the Standard stands without any recorded litigation or adjudicative gloss in its own text.

The Standard contains several provisions and linkages that create potential compliance pitfalls and operational risks for businesses, because obligations are often prescriptive about subject matter but leave technical implementation open. These are matters practitioners and compliance teams must note.

1. Use of an assessed cell line is mandatory but the list is external

• The requirement that only an assessed cell line be used for proliferation (3.4.1,7) ties permission to an external list in S25A,6. The Standard does not reproduce S25A,6, nor does it state criteria, application processes, or timelines for adding or removing lines. A business that believes a cell line is suitable must first confirm whether it appears on S25A,6 before proliferation, otherwise proliferation would be non‑compliant despite any internal safety measures.

2. Absence of explicit testing standards for prohibited agents

• Cell line suppliers must ensure a cell line does not contain bacteria, fungi, prions or viruses (3.4.1,3(1)). The Standard does not prescribe specific tests, thresholds, laboratory standards or accredited methods. Suppliers therefore face evidentiary and procedural uncertainty about what constitutes acceptable assurance of absence. They must choose testing regimes and document them in traceability and safety records.

3. Donor animal must be free of disease, but criteria are unspecified

• The duty that donor animals be free of disease (3.4.1,3(3)) lacks a defined list of diseases, testing intervals, or certification forms. Suppliers must interpret the requirement and document their risk‑based approach. That creates scope for regulatory or third‑party challenge where standards of “free of disease” are contested.

4. Parallel traceability duties across suppliers and processors

• Both cell line suppliers and cell culturing businesses have traceability obligations (3.4.1,4 and 3.4.1,9). The traceability systems must identify donor animals, supply recipients and the cell line used. Discrepant record formats or incompatible chain‑of‑custody systems between suppliers and processors may create gaps. Businesses must design interoperable records and contractual obligations to ensure the chain is intact.

5. Food safety program linkage without operational detail

• The food safety program must cover specific topics (3.4.1,5(2)), including indicators of loss of process control, identification of non‑conforming proliferation, and calibration, cleaning and sterilisation. The Standard does not define acceptable indicators or thresholds for loss of process control, nor does it specify calibration standards. Businesses must develop technically defensible criteria and document them in the program.

6. Cell biomass classified as potentially hazardous

• Declaring cell biomass a potentially hazardous food (3.4.1,8) imports obligations from Standard 3.2.2. However, 3.2.2 is not reproduced here, and its requirements (temperatures, shelf life, handling) may create strict storage and transport needs. Operators must consult Standard 3.2.2 to understand the full operational controls needed for storage and distribution.

7. Broad duty on inputs

• The requirement that any substance used in proliferation, differentiation, extraction, handling or storage must not make the food unsafe or unsuitable (3.4.1,6) means suppliers of media, sera, growth factors, scaffolds and storage materials must be vetted. The Standard’s wording does not confine the duty to certain classes of substances, increasing compliance breadth.

8. Definitions that constrain business models

• The cell line definition requires derivation from a single source and uniform composition (3.4.1,2). Multi‑source or pooled cell collections may not meet this definition and may therefore be excluded from being treated as a “cell line” under the Standard. Businesses relying on pooled sourcing should review whether their practices fall within the definition.

9. No express transitional or grandfathering clause

• The instrument gives no transitional provisions for existing cell lines, cell banks or ongoing projects. Where existing lines are not on S25A,6 or where record systems do not meet the traceability requirements, businesses must address compliance quickly from the date of gazettal.

10. Geographic limitation

• The Standard applies in Australia only (note 2). This raises practical issues for businesses operating cross‑border with New Zealand or exporting to other jurisdictions. They must map differing regulatory regimes and ensure compliance with this Australian Standard regardless of New Zealand practice.

11. No penalties or enforcement details in the text

• The Standard does not set out enforcement mechanisms or penalties, leaving businesses uncertain about the immediate legal consequences of non‑compliance and requiring them to consult applicable enforcement law outside the instrument.

Each of these points flows directly from the text of the Standard and its cross‑references. The common pattern is that the Standard prescribes subject matter obligations and gatekeeping rules, but omits technical detail, enforcement mechanics and external lists, creating implementation ambiguity that businesses must resolve through technical choices and records.

Compliance requires a programmatic approach that aligns documentary, operational and supplier controls to the duties set out in the Standard. Below is a practical compliance checklist structured against the Standard’s requirements and cross‑references. Each checklist item is grounded in the relevant section of Standard 3.4.1.

For cell line suppliers (3.4.1,3 and 3.4.1,4)

• Establish and document testing and assurance protocols to demonstrate that cell lines do not contain bacteria, fungi, prions or viruses (3.4.1,3(1)). While the Standard does not prescribe methods, record the chosen test methods, laboratories used, sampling regimes and acceptance criteria.
• Maintain auditable records identifying the species of cells comprising each cell line (3.4.1,3(2)). Include scientific names, source information and any genetic or cell‑identity assays relied upon.
• Implement donor animal health verification procedures (3.4.1,3(3)). Document veterinary assessments, test results and the basis for concluding the donor animal was free of disease at time of sourcing.
• Design and operate a traceability system that:
  • tracks cells from collection through to supply of a cell line;
  • identifies the donor animal for the cells used in each line;
  • records to whom a cell line was supplied (3.4.1,4). Ensure traceability data is retrievable, timestamped and linkable to production batches.

For cell culturing food businesses (3.4.1,5 to 3.4.1,9)

• Incorporate the Standard’s specified content into the business’s food safety program under Standard 3.2.1 (3.4.1,5(1)). The program should include:
  • indicators of loss of process control in the bioreactor (3.4.1,5(2)(a)). Define objective indicators, alarm thresholds, and response actions.
  • documented procedures for cell sourcing, selection and banking; serial sub‑culturing in flasks; seeding and proliferation in bioreactors; differentiation; and cell extraction (3.4.1,5(2)(b)(i)-(v). For each, specify critical control points, acceptable parameters and monitoring frequency.
  • non‑conformance detection and response mechanisms for cell proliferation (3.4.1,5(2)(c)). Specify criteria for stopping a proliferation run, hold procedures, disposition pathways and corrective actions.
  • calibration, cleaning and sterilisation procedures for all relevant equipment (3.4.1,5(2)(d)). Maintain calibration certificates and cleaning logs.
• Verify that any substance used in proliferation, differentiation, extraction, handling or storage does not make cell‑cultured food unsafe or unsuitable (3.4.1,6). For each input (media, sera, supplements, scaffolds, storage materials), obtain supplier specifications, safety data, certificates of analysis and incorporate into the hazard analysis.
• Confirm the cell line intended for proliferation appears on the assessed cell line list (S25A,6) before commencing proliferation (3.4.1,7). Retain documentation demonstrating the line’s assessed status at the time of use.
• Manage cell biomass using the controls appropriate to potentially hazardous foods under Standard 3.2.2 (3.4.1,8). Consult and implement the relevant temperature controls, storage conditions and labelling obligations required by 3.2.2.
• Implement traceability that identifies the cell line used for proliferation, the supplier of that cell line, and to whom the cell biomass was supplied (3.4.1,9). Ensure batch or lot identifiers tie cell biomass back to the originating line and supplier.

Operational and contractual measures

• Contractually require upstream suppliers (cell line suppliers, media suppliers, equipment vendors) to provide specifications, testing records and warranties aligned with the Standard’s duties.
• Ensure supplier contracts flow down obligations for traceability, donor‑animal records and absence of listed contaminants.
• For inter‑company transfers and recipients, use unique identifiers and require confirmation of receipt and storage conditions to maintain traceability chains.

Record retention and auditability

• While the Standard does not set record retention periods, maintain records sufficient to demonstrate compliance including species identification, donor animal health evidence, test reports for absence of bacteria/fungi/prions/viruses, production batch records, calibration and cleaning logs, and traceability logs linking suppliers and recipients.
• Prepare for audits by regulators by structuring records to show how each duty in the Standard is met.

Risk management and quality assurance

• Integrate the Standard’s obligations into existing HACCP or food safety management systems under Standard 3.2.1. Use the food safety program to document hazard analyses that specifically address cell culture risks and to map critical control points for bioreactors and cell extraction.
• Establish internal verification and validation activities to confirm that testing regimes, process indicators and cleaning/calibration schedules are effective.

Cross‑reference other Code obligations

• Consult Standard 3.2.2 for specific controls applicable to potentially hazardous foods and ensure cell biomass handling complies.
• Track amendments to S25A,6 so production plans remain aligned with the assessed cell line list. Do not commence proliferation with a line absent from S25A,6.

Implementation planning

• Conduct a gap analysis against each clause in 3.4.1 and produce an implementation plan that addresses documentation, capital or operational upgrades (e.g. calibration equipment, sterile handling capability), supplier onboarding, and staff training.
• Where existing cell lines or cell banks are in use, verify their assessed status and traceability records. Address any gaps prior to proliferation.

This checklist flows directly from the Standard’s sections and cross‑references. Where the Standard prescribes subjects but not technical specifics, businesses should document technically robust, risk‑based methods and retain evidence to support compliance.